DOJ Says Drug-Testing, Pharma Interests Have Financial Stake in Blocking Marijuana Move to Schedule III
WASHINGTON DC - The U.S. Department of Justice is accusing some of the most vocal opponents of federal marijuana rescheduling of trying to protect their own financial interests rather than public health. In a court filing submitted this week, DOJ attorneys argued that the National Drug and Alcohol Screening Association (NDASA) and MMJ International Holdings,
